Yalcin, A. D., Bisgin, A., Kargi, A., & Gorczynski, R. M. (2012). Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment. International Scientific Literature, Inc.
Chicago ZitierstilYalcin, Arzu Didem, Atil Bisgin, Aysegul Kargi, und Reginald M. Gorczynski. Serum-soluble TRAIL Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment. International Scientific Literature, Inc, 2012.
MLA ZitierstilYalcin, Arzu Didem, Atil Bisgin, Aysegul Kargi, und Reginald M. Gorczynski. Serum-soluble TRAIL Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment. International Scientific Literature, Inc, 2012.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.